Glucosamine medication

RX_GLUCOSAMINE

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC M01AX05

1 out of 7 registries used, show all original rules.

20126

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

20126

diagram downward connector

Include endpoints None

20126

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

19596

diagram downward connector
RX_GLUCOSAMINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 19596 13705 5891
Unadjusted prevalence (%) 4.76 5.95 3.24
Mean age at first event (years) 60.32 59.83 61.47

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.39 [1.19, 1.62] 2.2e-5 2416
15 years 0.01 1.24 [1.07, 1.44] 3.9e-3 1883
5 years 0.00 0.92 [0.78, 1.07] 2.7e-1 326
1 year 0.00 0.30 [0.18, 0.48] 5.5e-7 18

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 1

Survival analyses between endpoints

Plot

before Glucosamine medication
after Glucosamine medication

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Glucosamine medication

Endpoint not on priority list, no data to show.